Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study

Authors: Eric Yuk Fai Wan, Daniel Yee Tak Fong, Colman Siu Cheung Fung, Esther Yee Tak Yu, Weng Yee Chin, Anca Ka Chun Chan, Cindy Lo Kuen Lam

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Since diabetes mellitus (DM) is the leading cause of end stage renal disease (ESRD), this study aimed to develop a 5-year ESRD risk prediction model among Chinese patients with Type 2 DM (T2DM) in primary care.

Methods

A retrospective cohort study was conducted on 149,333 Chinese adult T2DM primary care patients without ESRD in 2010. Using the derivation cohort over a median of 5 years follow-up, the gender-specific models including the interaction effect between predictors and age were derived using Cox regression with a forward stepwise approach. Harrell’s C-statistic and calibration plot were applied to the validation cohort to assess discrimination and calibration of the models.

Results

Prediction models showed better discrimination with Harrell’s C-statistics of 0.866 (males) and 0.862 (females) and calibration power from the plots than other established models. The predictors included age, usages of anti-hypertensive drugs, anti-glucose drugs, and Hemogloblin A1c, blood pressure, urine albumin/creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). Specific predictors for male were smoking and presence of sight threatening diabetic retinopathy while additional predictors for female included longer duration of diabetes and quadratic effect of body mass index. Interaction factors with age showed a greater weighting of insulin and urine ACR in younger males, and eGFR in younger females.

Conclusions

Our newly developed gender-specific models provide a more accurate 5-year ESRD risk predictions for Chinese diabetic primary care patients than other existing models. The models included several modifiable risk factors that clinicians can use to counsel patients, and to target at in the delivery of care to patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference International Diabetes Federation: IDF Diabetes Atlas, 7 ed. Brussels: International Diabetes Federation; 2015. International Diabetes Federation: IDF Diabetes Atlas, 7 ed. Brussels: International Diabetes Federation; 2015.
3.
go back to reference Atkins RC, Zimmet P. Diabetic kidney disease: act now or pay later—world kidney day, 11 march 2010. Ther Apher Dial. 2010;14(1):1–4.CrossRefPubMed Atkins RC, Zimmet P. Diabetic kidney disease: act now or pay later—world kidney day, 11 march 2010. Ther Apher Dial. 2010;14(1):1–4.CrossRefPubMed
4.
go back to reference Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, Arima H, Zoungas S, Cass A, Patel A, Marre M. Prediction of kidney-related outcomes in patients with type 2 diabetes. Am J Kidney Dis. 2012;60(5):770–8.CrossRefPubMed Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, Arima H, Zoungas S, Cass A, Patel A, Marre M. Prediction of kidney-related outcomes in patients with type 2 diabetes. Am J Kidney Dis. 2012;60(5):770–8.CrossRefPubMed
5.
go back to reference Sievers ML, Nelson RG, Knowler WC, Bennett PH. Impact of NIDDM on mortality and causes of death in pima Indians. Diabetes Care. 1992;15(11):1541–9.CrossRefPubMed Sievers ML, Nelson RG, Knowler WC, Bennett PH. Impact of NIDDM on mortality and causes of death in pima Indians. Diabetes Care. 1992;15(11):1541–9.CrossRefPubMed
6.
go back to reference Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC, Weintraub RM, Hernandez F, Olmstead EM, Nugent WC. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation. 2004;110(11 suppl 1):II-41–4. Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC, Weintraub RM, Hernandez F, Olmstead EM, Nugent WC. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation. 2004;110(11 suppl 1):II-41–4.
7.
go back to reference Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY-M, Yang C-W. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.CrossRefPubMed Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY-M, Yang C-W. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.CrossRefPubMed
8.
go back to reference American Diabetes Association. Standards of medical care in diabetes—2016 abridged for primary care providers. Clinical diabetes: a publication of the American Diabetes Association. 2016;34(1):3. American Diabetes Association. Standards of medical care in diabetes—2016 abridged for primary care providers. Clinical diabetes: a publication of the American Diabetes Association. 2016;34(1):3.
9.
go back to reference McGuire H, Longson D, Adler A, Farmer A, Lewin I. Management of type 2 diabetes in adults: summary of updated NICE guidance. British Med J. 2016;353. McGuire H, Longson D, Adler A, Farmer A, Lewin I. Management of type 2 diabetes in adults: summary of updated NICE guidance. British Med J. 2016;353.
10.
go back to reference Hippisley-Cox J, Coupland C: Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney® scores. BMC Fam Pract 2010, 11(1):1. Hippisley-Cox J, Coupland C: Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney® scores. BMC Fam Pract 2010, 11(1):1.
11.
go back to reference Chien K-L, Lin H-J, Lee B-C, Hsu H-C, Lee Y-T, Chen M-F. A prediction model for the risk of incident chronic kidney disease. Am J Med. 2010;123(9):836–46. e832CrossRefPubMed Chien K-L, Lin H-J, Lee B-C, Hsu H-C, Lee Y-T, Chen M-F. A prediction model for the risk of incident chronic kidney disease. Am J Med. 2010;123(9):836–46. e832CrossRefPubMed
12.
go back to reference Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, Gipson D, Colindres RE, Kshirsagar AV. SCreening for occult REnal disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167(4):374–81.CrossRefPubMed Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, Gipson D, Colindres RE, Kshirsagar AV. SCreening for occult REnal disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167(4):374–81.CrossRefPubMed
13.
go back to reference Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diab Am Diab Assoc. 2000;49(3):476–84. Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diab Am Diab Assoc. 2000;49(3):476–84.
14.
go back to reference Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt K-U. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93–104.CrossRefPubMedPubMedCentral Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt K-U. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93–104.CrossRefPubMedPubMedCentral
15.
go back to reference Elley CR, Robinson T, Moyes SA, Kenealy T, Collins J, Robinson E, Orr-Walker B, Drury PL. Derivation and validation of a renal risk score for people with type 2 diabetes. Diabetes Care. 2013;36(10):3113–20.CrossRefPubMedPubMedCentral Elley CR, Robinson T, Moyes SA, Kenealy T, Collins J, Robinson E, Orr-Walker B, Drury PL. Derivation and validation of a renal risk score for people with type 2 diabetes. Diabetes Care. 2013;36(10):3113–20.CrossRefPubMedPubMedCentral
16.
go back to reference Burrows NR, Li Y, Williams DE. Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005. Adv Chronic Kidney Dis. 2008;15(2):147–52.CrossRefPubMed Burrows NR, Li Y, Williams DE. Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005. Adv Chronic Kidney Dis. 2008;15(2):147–52.CrossRefPubMed
17.
go back to reference McClellan WM, Warnock DG, Judd S, Muntner P, Kewalramani R, Cushman M, McClure LA, Newsome BB, Howard G. Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol. 2011;22(9):1721–8.CrossRefPubMedPubMedCentral McClellan WM, Warnock DG, Judd S, Muntner P, Kewalramani R, Cushman M, McClure LA, Newsome BB, Howard G. Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol. 2011;22(9):1721–8.CrossRefPubMedPubMedCentral
18.
go back to reference Kong AP, Xu G, Brown N, So W-Y, Ma RC, Chan JC. Diabetes and its comorbidities—where east meets west. Nat Rev Endocrinol. 2013;9(9):537–47.CrossRefPubMed Kong AP, Xu G, Brown N, So W-Y, Ma RC, Chan JC. Diabetes and its comorbidities—where east meets west. Nat Rev Endocrinol. 2013;9(9):537–47.CrossRefPubMed
19.
go back to reference Yang X, So W, Kong A, Clarke P, Ho C, Lam C, Ng M, Lyu R, Yin D, Chow C. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong diabetes registry. Diabetologia. 2006;49(10):2299–308.CrossRefPubMed Yang X, So W, Kong A, Clarke P, Ho C, Lam C, Ng M, Lyu R, Yin D, Chow C. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong diabetes registry. Diabetologia. 2006;49(10):2299–308.CrossRefPubMed
20.
go back to reference Fung CS, Chin WY, Dai DS, Kwok RL, Tsui EL, Wan YF, Wong W, Wong CK, Fong DY, Lam CL. Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients. BMC Fam Pract. 2012;13(1):116.CrossRefPubMedPubMedCentral Fung CS, Chin WY, Dai DS, Kwok RL, Tsui EL, Wan YF, Wong W, Wong CK, Fong DY, Lam CL. Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients. BMC Fam Pract. 2012;13(1):116.CrossRefPubMedPubMedCentral
21.
go back to reference Royston P. Multiple imputation of missing values. Stata J. 2004;4:227–41. Royston P. Multiple imputation of missing values. Stata J. 2004;4:227–41.
22.
go back to reference Rubin DB: Multiple imputation for nonresponse in surveys, vol. 81. USA: John Wiley & Sons; 2004. Rubin DB: Multiple imputation for nonresponse in surveys, vol. 81. USA: John Wiley & Sons; 2004.
23.
go back to reference Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease a meta-analysis. J Am Soc Nephrol. 2000;11(2):319–29.PubMed Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease a meta-analysis. J Am Soc Nephrol. 2000;11(2):319–29.PubMed
24.
go back to reference Gall M-A, Hougaard P, Borch-Johnsen K, Parving H-H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ. 1997;314(7083):783.CrossRefPubMedPubMedCentral Gall M-A, Hougaard P, Borch-Johnsen K, Parving H-H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ. 1997;314(7083):783.CrossRefPubMedPubMedCentral
25.
go back to reference Eriksen B, Ingebretsen O. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69(2):375–82.CrossRefPubMed Eriksen B, Ingebretsen O. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69(2):375–82.CrossRefPubMed
26.
go back to reference Radcliffe NJ, Seah Jm, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI. Clinical predictive factors in diabetic kidney disease progression. J Diab Invest. 2017;8(1):6–18. Radcliffe NJ, Seah Jm, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI. Clinical predictive factors in diabetic kidney disease progression. J Diab Invest. 2017;8(1):6–18.
27.
go back to reference Tsai W-C, Wu H-Y, Peng Y-S, Ko M-J, Wu M-S, Hung K-Y, Wu K-D, Chu T-S, Chien K-L. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine. 2016;95(11):e3013.CrossRefPubMedPubMedCentral Tsai W-C, Wu H-Y, Peng Y-S, Ko M-J, Wu M-S, Hung K-Y, Wu K-D, Chu T-S, Chien K-L. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine. 2016;95(11):e3013.CrossRefPubMedPubMedCentral
28.
go back to reference Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, de Jong PE, Group PS. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol. 2003;14(5):1330–5.CrossRefPubMed Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, de Jong PE, Group PS. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol. 2003;14(5):1330–5.CrossRefPubMed
29.
go back to reference Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334(1):13–8.CrossRefPubMed Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334(1):13–8.CrossRefPubMed
30.
go back to reference Bell EK, Gao L, Judd S, Glasser SP, McClellan W, Gutiérrez OM, Safford M, Lackland DT, Warnock DG, Muntner P. Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am J Hypertens. 2012;25(7):789.CrossRefPubMedPubMedCentral Bell EK, Gao L, Judd S, Glasser SP, McClellan W, Gutiérrez OM, Safford M, Lackland DT, Warnock DG, Muntner P. Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am J Hypertens. 2012;25(7):789.CrossRefPubMedPubMedCentral
31.
32.
go back to reference Ma RC, Chan JC. Type 2 diabetes in east Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281(1):64–91.CrossRefPubMedPubMedCentral Ma RC, Chan JC. Type 2 diabetes in east Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281(1):64–91.CrossRefPubMedPubMedCentral
33.
go back to reference Chan JC, So W, Ma RC, Tong PC, Wong R, Yang X. The complexity of vascular and non-vascular complications of diabetes: the Hong Kong diabetes registry. Curr Cardiovasc Risk Rep. 2011;5(3):230–9.CrossRefPubMedPubMedCentral Chan JC, So W, Ma RC, Tong PC, Wong R, Yang X. The complexity of vascular and non-vascular complications of diabetes: the Hong Kong diabetes registry. Curr Cardiovasc Risk Rep. 2011;5(3):230–9.CrossRefPubMedPubMedCentral
34.
go back to reference Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14centres: the world health organization multinational study of vascular disease in diabetics. Diabetologia. 1985;28:615–40.CrossRef Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14centres: the world health organization multinational study of vascular disease in diabetics. Diabetologia. 1985;28:615–40.CrossRef
35.
go back to reference Chi Z, Lee E, Lu M, Keen H, Bennett P, Group WMS. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(2):S82–6.CrossRefPubMed Chi Z, Lee E, Lu M, Keen H, Bennett P, Group WMS. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(2):S82–6.CrossRefPubMed
36.
go back to reference Liu J, Lim S, Yeoh L, Su C, Tai B, Low S, Fun S, Tavintharan S, Chia K, Tai E. Ethnic disparities in risk of cardiovascular disease, end-stage renal disease and all-cause mortality: a prospective study among Asian people with type 2 diabetes. Diabet Med. 2016;33(3):332–9.CrossRefPubMed Liu J, Lim S, Yeoh L, Su C, Tai B, Low S, Fun S, Tavintharan S, Chia K, Tai E. Ethnic disparities in risk of cardiovascular disease, end-stage renal disease and all-cause mortality: a prospective study among Asian people with type 2 diabetes. Diabet Med. 2016;33(3):332–9.CrossRefPubMed
37.
go back to reference Mooyaart A, Valk E, Van Es L, Bruijn J, De Heer E, Freedman B, Dekkers O, Baelde H. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011;54(3):544–53.CrossRefPubMed Mooyaart A, Valk E, Van Es L, Bruijn J, De Heer E, Freedman B, Dekkers O, Baelde H. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011;54(3):544–53.CrossRefPubMed
38.
go back to reference Silbiger S, Neugarten J. Gender and human chronic renal disease. Gender Med. 2008;5:S3–S10.CrossRef Silbiger S, Neugarten J. Gender and human chronic renal disease. Gender Med. 2008;5:S3–S10.CrossRef
39.
go back to reference Molitch ME, Adler AI, Flyvbjerg A, Nelson RG, So W-Y, Wanner C, Kasiske BL, Wheeler DC, De Zeeuw D, Mogensen CE. Diabetic kidney disease: a clinical update from kidney disease: improving global outcomes. Kidney Int. 2015;87(1):20–30.CrossRefPubMed Molitch ME, Adler AI, Flyvbjerg A, Nelson RG, So W-Y, Wanner C, Kasiske BL, Wheeler DC, De Zeeuw D, Mogensen CE. Diabetic kidney disease: a clinical update from kidney disease: improving global outcomes. Kidney Int. 2015;87(1):20–30.CrossRefPubMed
40.
go back to reference Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and nutrition examination survey. Am J Kidney Dis. 2003;41(1):1–12.CrossRefPubMed Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and nutrition examination survey. Am J Kidney Dis. 2003;41(1):1–12.CrossRefPubMed
41.
go back to reference De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P. Predictors of chronic kidney disease in type 2 diabetes: a longitudinal study from the AMD annals initiative. Medicine. 2016:95(27). De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P. Predictors of chronic kidney disease in type 2 diabetes: a longitudinal study from the AMD annals initiative. Medicine. 2016:95(27).
Metadata
Title
Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study
Authors
Eric Yuk Fai Wan
Daniel Yee Tak Fong
Colman Siu Cheung Fung
Esther Yee Tak Yu
Weng Yee Chin
Anca Ka Chun Chan
Cindy Lo Kuen Lam
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0671-x

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue